155 related articles for article (PubMed ID: 38310540)
1. Increased expression of complement C3c, iC3b, and cells containing CD11b or CD14 in experimentally induced psoriatic lesion.
Rahkola D; Harvima RJ; Harvima IT
Clin Exp Immunol; 2024 May; 216(3):252-261. PubMed ID: 38310540
[TBL] [Abstract][Full Text] [Related]
2. Sequential Increase in Complement Factor I, iC3b, and Cells Expressing CD11b or CD14 in Cutaneous Vasculitis.
Rahkola D; Lipitsä T; Siiskonen H; Naukkarinen A; Harvima IT
Anal Cell Pathol (Amst); 2022; 2022():3888734. PubMed ID: 35747245
[TBL] [Abstract][Full Text] [Related]
3. Mast Cells Are a Marked Source for Complement C3 Products That Associate with Increased CD11b-Positive Cells in Keratinocyte Skin Carcinomas.
Rahkola D; Laitala J; Siiskonen H; Pelkonen J; Harvima IT
Cancer Invest; 2019; 37(2):73-84. PubMed ID: 30689427
[TBL] [Abstract][Full Text] [Related]
4. Experimentally induced psoriatic lesion associates with interleukin (IL)-6 in mast cells and appearance of dermal cells expressing IL-33 and IL-6 receptor.
Suttle MM; Nilsson G; Snellman E; Harvima IT
Clin Exp Immunol; 2012 Sep; 169(3):311-9. PubMed ID: 22861371
[TBL] [Abstract][Full Text] [Related]
5. Experimentally induced psoriatic lesions associate with rapid but transient decrease in interleukin-33 immunostaining in epidermis.
Suttle MM; Enoksson M; Zoltowska A; Chatterjee M; Nilsson G; Harvima IT
Acta Derm Venereol; 2015 May; 95(5):536-41. PubMed ID: 25425229
[TBL] [Abstract][Full Text] [Related]
6. Bovine conglutinin binds to an oligosaccharide determinant presented by iC3b, but not by C3, C3b or C3c.
Laursen SB; Thiel S; Teisner B; Holmskov U; Wang Y; Sim RB; Jensenius JC
Immunology; 1994 Apr; 81(4):648-54. PubMed ID: 7518801
[TBL] [Abstract][Full Text] [Related]
7. iC3b arrests monocytic cell differentiation into CD1c-expressing dendritic cell precursors: a mechanism for transiently decreased dendritic cells in vivo after human skin injury by ultraviolet B.
Takahara M; Kang K; Liu L; Yoshida Y; McCormick TS; Cooper KD
J Invest Dermatol; 2003 May; 120(5):802-9. PubMed ID: 12713585
[TBL] [Abstract][Full Text] [Related]
8. Generation of three different fragments of bound C3 with purified factor I or serum. II. Location of binding sites in the C3 fragments for factors B and H, complement receptors, and bovine conglutinin.
Ross GD; Newman SL; Lambris JD; Devery-Pocius JE; Cain JA; Lachmann PJ
J Exp Med; 1983 Aug; 158(2):334-52. PubMed ID: 6224880
[TBL] [Abstract][Full Text] [Related]
9. Mutagenesis of the Arg-Gly-Asp triplet in human complement component C3 does not abolish binding of iC3b to the leukocyte integrin complement receptor type III (CR3, CD11b/CD18).
Taniguchi-Sidle A; Isenman DE
J Biol Chem; 1992 Jan; 267(1):635-43. PubMed ID: 1730624
[TBL] [Abstract][Full Text] [Related]
10. Monocyte induction of IL-10 and down-regulation of IL-12 by iC3b deposited in ultraviolet-exposed human skin.
Yoshida Y; Kang K; Berger M; Chen G; Gilliam AC; Moser A; Wu L; Hammerberg C; Cooper KD
J Immunol; 1998 Dec; 161(11):5873-9. PubMed ID: 9834066
[TBL] [Abstract][Full Text] [Related]
11. Functional assessment of mouse complement pathway activities and quantification of C3b/C3c/iC3b in an experimental model of mouse renal ischaemia/reperfusion injury.
Kotimaa JP; van Werkhoven MB; O'Flynn J; Klar-Mohamad N; van Groningen J; Schilders G; Rutjes H; Daha MR; Seelen MA; van Kooten C
J Immunol Methods; 2015 Apr; 419():25-34. PubMed ID: 25733354
[TBL] [Abstract][Full Text] [Related]
12. The crystal structure of iC3b-CR3 αI reveals a modular recognition of the main opsonin iC3b by the CR3 integrin receptor.
Fernández FJ; Santos-López J; Martínez-Barricarte R; Querol-García J; Martín-Merinero H; Navas-Yuste S; Savko M; Shepard WE; Rodríguez de Córdoba S; Vega MC
Nat Commun; 2022 Apr; 13(1):1955. PubMed ID: 35413960
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a monoclonal antibody MoAb bH6 reacting with a neoepitope of human C3 expressed on C3b, iC3b, and C3c.
Garred P; Mollnes TE; Lea T; Fischer E
Scand J Immunol; 1988 Mar; 27(3):319-27. PubMed ID: 2451273
[TBL] [Abstract][Full Text] [Related]
14. Increase in complement iC3b is associated with anti-inflammatory cytokine expression during late pregnancy in mice.
Nakamura K; Kusama K; Bai R; Ishikawa S; Fukushima S; Suda Y; Imakawa K
PLoS One; 2017; 12(5):e0178442. PubMed ID: 28542608
[TBL] [Abstract][Full Text] [Related]
15. Physiologic inactivation of fluid phase C3b: isolation and structural analysis of C3c, C3d,g (alpha 2D), and C3g.
Davis AE; Harrison RA; Lachmann PJ
J Immunol; 1984 Apr; 132(4):1960-6. PubMed ID: 6607952
[TBL] [Abstract][Full Text] [Related]
16. Effect of antigen site and complement receptor status on the rate of cleavage of C3c antigen from red cell bound C3b.
Currie MS; Rustagi PK; Wojcieszak R; Ziolkowski L; Ross GD; Logue GL
Blood; 1988 Mar; 71(3):786-90. PubMed ID: 3345346
[TBL] [Abstract][Full Text] [Related]
17. Levels of complement components iC3b, C3c, C4, and SC5b-9 in peritoneal fluid and serum of infertile women with endometriosis.
Kabut J; Kondera-Anasz Z; Sikora J; Mielczarek-Palacz A
Fertil Steril; 2007 Nov; 88(5):1298-303. PubMed ID: 17482181
[TBL] [Abstract][Full Text] [Related]
18. The CD11b/CD18-integrin in the pathogenesis of psoriasis.
van Pelt JP; Kuijpers SH; van de Kerkhof PC; de Jong EM
J Dermatol Sci; 1998 Jan; 16(2):135-43. PubMed ID: 9459126
[TBL] [Abstract][Full Text] [Related]
19. Innate immune-related receptors in normal and psoriatic skin.
Curry JL; Qin JZ; Bonish B; Carrick R; Bacon P; Panella J; Robinson J; Nickoloff BJ
Arch Pathol Lab Med; 2003 Feb; 127(2):178-86. PubMed ID: 12562231
[TBL] [Abstract][Full Text] [Related]
20. The attachment of serum- and plasma-derived C3 to solid-phase immune aggregates and its relation to complement-mediated solubilization of immune complexes.
Baatrup G; Svehag SE; Jensenius JC
Scand J Immunol; 1986 Apr; 23(4):397-406. PubMed ID: 3486458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
